Skip to main content

Table 1 Clinical characteristics of patients in this study

From: Diagnostic utility of LunXmRNA in peripheral blood and pleural fluid in patients with primary non-small cell lung cancer

 

Peripheral blood

Pleural fluid

 

Lung cancer

Esophagus cancer

Breast cancer

Pneumonia

Healthy

Lung cancer

Tuberculo pleurisy

Age mean (min-max)

67(36–89)

62(39–85)

51(35–82)

67(52–83)

42(25–60)

66(36–85)

64(24–85)

Sex (M/F)

31/13

5/3

0/20

8/2

8/7

9/5

12/2

Pathologic stage

       

I

8

1

3

-

-

-

-

II

8

3

8

-

-

-

-

III

14

2

5

-

-

5

-

IV

14

2

4

-

-

9

-

Pathologic Typing

       
 

Squ 26

Squ 6

-

-

-

Squ 9

-

 

Ade 16

Ade 2

-

-

-

Ade 5

-

 

LCLC 2

-

-

-

-

LCLC

-

Total number

44

8

20

10

15

14

14

  1. Pathologic stage was determined as I, II, III or IV according to the American Joint Committee On Cancer (AJCC) TNM system. Squ = squamous epithelial carcinoma; Ade = adenocarcinoma; LCLC = large cell lung cancer.
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us